Azenta completes B Medical divestiture as Thelema repays vendor loan

Corporate Action
โดย Seeking Alpha·US·Read original
Summary · why it matters

Life sciences company Azenta announced on Friday that it has completed the divestiture of its B Medical Systems after Thelema S.à r.l., which acquired the medical refrigeration devices maker in July, repaid a $35 million vendor loan related to the deal. The Luxembourg-based Thelema completed the purchase of B Medical Systems following a 2025 deal worth $63 million, with $35 million of that funded through a short-term vendor loan from an Azenta subsidiary. The vendor loan was repaid in full ahead of maturity along with accrued interest, and Azenta has released the equity interests tied to the deal, completing the divestiture. Interim CEO Martin Madaus said Azenta has now received the entire purchase price in cash, and the credit exposure associated with the transaction has been retired, supporting the company's disciplined approach to capital allocation.

Impact on stocks 1

Biotech & Genomic Medicine · 1 stocks
Azenta Inc
AZTA
▲ PositiveCapitalrelevance

Completed divestiture and full repayment of vendor loan, receiving entire purchase price in cash and retiring credit exposure.

Off-coverage companies 2

B Medical SystemsPrivate± Mixed
relevance

Thelema S.à r.l.Private± Mixed
relevance